Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder

Clinical trial NCT01822678 · COMPLETED

Trial details

NCT number: NCT01822678
Sponsor: Bial - Portela C S.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bipolar I Disorder

Start date: 2005-12-01
Primary completion: 2006-11-01
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.